Buruli ulcer: reductive evolution enhances pathogenicity of Mycobacterium ulcerans, Nat. Rev. Microbiol, vol.7, pp.50-60, 2009. ,
Buruli ulcer: emerging from obscurity, Lancet, vol.367, pp.1849-1858, 2006. ,
Efficacy of the combination rifampin-streptomycin in preventing growth of Mycobacterium ulcerans in early lesions of Buruli ulcer in humans, Antimicrob. Agents Chemother, vol.49, pp.3182-3186, 2005. ,
Buruli ulcer disease: prospects for a vaccine, Med. Microbiol. Immunol. (Berl.), vol.198, pp.69-77, 2009. ,
Lipids of pathogenic Mycobacteria: contributions to virulence and host immune suppression, Transbound Emerg Dis, vol.56, pp.255-268, 2009. ,
, Mycolactone: a polyketide toxin from Mycobacterium ulcerans required for virulence, vol.283, pp.854-857, 1999.
Histopathologic features of Mycobacterium ulcerans infection, Emerg. Infect. Dis, vol.9, pp.651-656, 2003. ,
A Mycobacterium ulcerans toxin, mycolactone, causes apoptosis in guinea pig ulcers and tissue culture cells, Infect. Immun, vol.68, pp.877-883, 2000. ,
Mycolactones: immunosuppressive and cytotoxic polyketides produced by aquatic mycobacteria, Nat. Prod. Rep, vol.25, pp.447-454, 2008. ,
Modulation of the host immune response by a transient intracellular stage of Mycobacterium ulcerans: the contribution of endogenous mycolactone toxin, Cell. Microbiol, vol.7, pp.1187-1196, 2005. ,
The inhibitory action of Mycobacterium ulcerans soluble factor on monocyte/T cell cytokine production and NF-k B function, J. Immunol, vol.163, pp.3928-3935, 1999. ,
Mycolactone-mediated inhibition of tumor necrosis factor production by macrophages infected with Mycobacterium ulcerans has implications for the control of infection, Infect. Immun, vol.75, pp.3979-3988, 2007. ,
Mycolactone inhibits monocyte cytokine production by a posttranscriptional mechanism, J. Immunol, vol.182, pp.2194-2202, 2009. ,
Selective suppression of dendritic cell functions by Mycobacterium ulcerans toxin mycolactone, J. Exp. Med, vol.204, pp.1395-1403, 2007. ,
URL : https://hal.archives-ouvertes.fr/pasteur-01402321
Immunosuppressive signature of cutaneous Mycobacterium ulcerans infection in the peripheral blood of patients with buruli ulcer disease, J. Infect. Dis, vol.200, pp.1675-1684, 2009. ,
URL : https://hal.archives-ouvertes.fr/pasteur-01402286
Acquired T-helper 1 lymphocyte anergy following infection with Mycobacterium ulcerans, Clin. Infect. Dis, vol.36, pp.1076-1077, 2003. ,
Cytokine response to antigen stimulation of whole blood from patients with Mycobacterium ulcerans disease compared to that from patients with tuberculosis, Clin. Vaccine Immunol, vol.13, pp.253-257, 2006. ,
Differential production of systemic and intralesional g interferon and interleukin-10 in nodular and ulcerative forms of Buruli disease, Infect. Immun, vol.72, pp.958-965, 2004. ,
Cytokine responses to stimulation of whole blood from patients with Buruli ulcer disease in Ghana, Clin. Diagn. Lab. Immunol, vol.12, pp.125-129, 2005. ,
Systemic suppression of interferon-g responses in Buruli ulcer patients resolves after surgical excision of the lesions caused by the extracellular pathogen Mycobacterium ulcerans, J. Leukoc. Biol, vol.79, pp.1150-1156, 2006. ,
Development of highly organized lymphoid structures in buruli ulcer lesions after treatment with rifampicin and streptomycin, PLoS Negl. Trop. Dis, vol.1, p.2, 2007. ,
Immunosuppression and treatment-associated inflammatory response in patients with Mycobacterium ulcerans infection (Buruli ulcer), Expert Opin. Biol. Ther, vol.9, pp.187-200, 2009. ,
Dynamics of the cytokine response to Mycobacterium ulcerans during antibiotic treatment for M. ulcerans disease (Buruli ulcer) in humans, Clin. Vaccine Immunol, vol.16, pp.61-65, 2009. ,
Mycolactone diffuses from Mycobacterium ulcerans-infected tissues and targets mononuclear cells in peripheral blood and lymphoid organs, PLoS Negl. Trop. Dis, vol.2, p.325, 2008. ,
The architecture of the interleukin-2 promoter: a reflection of T lymphocyte activation, Biochim. Biophys. Acta, vol.1263, pp.181-200, 1995. ,
Rapamycin blocks the phosphorylation of 4E-BP1 and inhibits cap-dependent initiation of translation, EMBO J, vol.15, pp.658-664, 1996. ,
Rapamycin-FKBP specifically blocks growth-dependent activation of and signaling by the 70 kd S6 protein kinases, Cell, vol.69, pp.1227-1236, 1992. ,
An integrated stress response regulates amino acid metabolism and resistance to oxidative stress, Mol. Cell, vol.11, pp.619-633, 2003. ,
Tailoring T-cell receptor signals by proximal negative feedback mechanisms, Nat. Rev. Immunol, vol.8, pp.699-712, 2008. ,
URL : https://hal.archives-ouvertes.fr/pasteur-00369557
Activation of the Lck tyrosine kinase targets cell surface T cell antigen receptors for lysosomal degradation, Immunity, vol.7, pp.619-628, 1997. ,
Uptake and cellular actions of mycolactone, a virulence determinant for Mycobacterium ulcerans, Microb. Pathog, vol.34, pp.91-101, 2003. ,
Calcium signalling in lymphocyte activation and disease, Nat. Rev. Immunol, vol.7, pp.690-702, 2007. ,
Defective TCR stimulation in anergized type 2 T helper cells correlates with abrogated p56 (lck) and ZAP-70 tyrosine kinase activities, J. Immunol, vol.159, pp.53-60, 1997. ,
Anergic T-lymphocyte clones have altered inositol phosphate, calcium, and tyrosine kinase signaling pathways, Proc. Natl. Acad. Sci, vol.91, pp.38-42, 1994. ,
Maintenance of B cell anergy requires constant antigen receptor occupancy and signaling, Nat. Immunol, vol.6, pp.1160-1167, 2005. ,
Src-family kinases: rheostats of immune cell signaling, Mol. Immunol, vol.41, pp.631-643, 2004. ,